Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18712 | 473 | 34.4 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HMC05 | Author keyword | 9 | 83% | 1% | 5 |
2 | HEBEI PROV PEOPLES HOSP | Address | 2 | 67% | 0% | 2 |
3 | DIPARTIMENTO CHIRURG GEN PARIDE STEFANINI | Address | 1 | 50% | 0% | 2 |
4 | MEDCARDIAC CATHETERIZAT | Address | 1 | 33% | 0% | 2 |
5 | ANGINA PECTORIS EPIDEMIOLOGY | Author keyword | 1 | 50% | 0% | 1 |
6 | ANTI INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY | Author keyword | 1 | 50% | 0% | 1 |
7 | C REACTIVE PROTEIN ANALYSIS METABOLISM | Author keyword | 1 | 50% | 0% | 1 |
8 | CARDIAC RELEASE | Author keyword | 1 | 50% | 0% | 1 |
9 | ELECTIVE CORONARY STENTING | Author keyword | 1 | 50% | 0% | 1 |
10 | ENDOTHELIUM CELL ADHESION MOLECULES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROTIC RENAL STENOSIS | 9 | 83% | 1% | 5 |
2 | PREPROCEDURAL SERUM LEVELS | 5 | 63% | 1% | 5 |
3 | REDUCES NEOINTIMAL FORMATION | 4 | 31% | 3% | 12 |
4 | SEVERE UNSTABLE ANGINA | 3 | 23% | 2% | 11 |
5 | ARTERY STENT IMPLANTATION | 3 | 50% | 1% | 4 |
6 | POSTANGIOPLASTY RESTENOSIS | 1 | 33% | 1% | 3 |
7 | AGGREGATION INVITRO | 1 | 33% | 0% | 2 |
8 | ACCELERATES ANGIOGENESIS | 1 | 50% | 0% | 1 |
9 | BERBERINE IMPROVES | 1 | 50% | 0% | 1 |
10 | LEUKOCYTE ATTACK | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Inflammation and restenosis after percutaneous coronary interventions | 2004 | 92 | 61 | 44% |
The Important Role of Inflammatory Biomarkers Pre and Post Bare-Metal and Drug-Eluting Stent Implantation | 2012 | 12 | 37 | 35% |
Inflammation and restenosis in the stent era | 2002 | 299 | 57 | 21% |
Inflammation and Vascular Injury - Basic Discovery to Drug Development | 2012 | 25 | 76 | 17% |
Coronary stenting and inflammation: Implications for further surgical and medical treatment | 2006 | 29 | 63 | 33% |
Inflammatory Markers and Restenosis in Peripheral Percutaneous Angioplasty With Intravascular Stenting: Current Concepts | 2011 | 9 | 107 | 18% |
Prevention of restenosis after stenting: the emerging role of inflammation | 2004 | 31 | 33 | 24% |
Interleukin-6 and acute coronary syndrome | 2001 | 78 | 28 | 21% |
Liposomal alendronate for the treatment of restenosis | 2012 | 4 | 93 | 20% |
Appraisal of the Prognosis in Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention | 2009 | 2 | 13 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEBEI PROV PEOPLES HOSP | 2 | 67% | 0.4% | 2 |
2 | DIPARTIMENTO CHIRURG GEN PARIDE STEFANINI | 1 | 50% | 0.4% | 2 |
3 | MEDCARDIAC CATHETERIZAT | 1 | 33% | 0.4% | 2 |
4 | EPIDEMIOL CHRON NONCOMMUNICABLE DIS | 1 | 50% | 0.2% | 1 |
5 | FARZAN CLIN | 1 | 50% | 0.2% | 1 |
6 | KLINIKUM RECHTS ISAR MED KLIN 1 | 1 | 50% | 0.2% | 1 |
7 | MEDCARDIAC CATHETERIZAT CARDIOVASC | 1 | 50% | 0.2% | 1 |
8 | ONOFRE LOPES HOSP | 1 | 50% | 0.2% | 1 |
9 | RECHTS ISAR | 1 | 50% | 0.2% | 1 |
10 | SECT HOSP INFECT | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000202527 | VICTORIA JOHNSON//VCU PAULEY HEART//VICTORIA JOHNSON S |
2 | 0.0000166454 | C REACTIVE PROTEIN//HIGH SENSITIVITY C REACTIVE PROTEIN//CARDIOVASC DIS PREVENT |
3 | 0.0000150138 | LOCAL DRUG DELIVERY//HIRULOG LIKE PEPTIDE//ANGIOPEPTIN |
4 | 0.0000123503 | DRUG ELUTING STENT//DRUG ELUTING STENTS//STENT THROMBOSIS |
5 | 0.0000118020 | NEUTROPHIL TO LYMPHOCYTE RATIO//LEUKOCYTE COUNT//WHITE BLOOD CELL COUNT |
6 | 0.0000117240 | PERIPROCEDURAL MYOCARDIAL INFARCTION//PERIPROCEDURAL MYOCARDIAL INJURY//PERIOPERATIVE MYOCARDIAL INFARCTION |
7 | 0.0000116830 | MONOCYTE CHEMOATTRACTANT PROTEIN 1//MCP 1 POLYMORPHISM//REGULATED UPON ACTIVATION |
8 | 0.0000111897 | E SELECTIN//ROYAL CITY DUBLIN HOSP EDUC//E SELECTIN GENE |
9 | 0.0000081657 | CTHRC1//COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1//CAROTID ARTERY RESTENOSIS |
10 | 0.0000079847 | JOBST VASC SURG//CONRAD JOBST VASC S//SOLUBLE P SELECTIN |